DCC-2618
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DCC-2618, covering 2021-04-23 to 2025-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib [Phase 2]